| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695477 | Gynecologic Oncology | 2017 | 9 Pages |
Abstract
Expression of DNA damage response proteins in cervical cancer is associated with outcome in patients treated with CRT. Immunohistochemical analysis of these proteins may be useful in guiding treatment decisions in such patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
C.K. Ho, E.N. Kornaga, A.C. Klimowicz, E.K. Enwere, M. Dean, G.D. Bebb, T. Phan, P. Ghatage, A.M. Magliocco, S.P. Lees-Miller, C.M. Doll,